Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
Description Ligand conjugated antisense version of an oligonucleotide targeting apolipoprotein C-III (APOCIII; APOC3)
Molecular Target Apolipoprotein C-III (APOCIII) (APOC3)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today